GENERAL ORTHOPAEDICS
Bone marrow injection further benefits core decompression treatment for osteonecrosis
J Arthroplasty. 2015 Sep;30(9 Suppl):11-518 patients (28 hips) with early-stage osteonecrosis of the femoral head (ONFH) were randomly assigned to receive core decompression with or without an autologous bone marrow stem cell injection. The purpose of this study was to investigate the clinical effects of concentrated bone marrow injection when used in combination with core decompression, and observe its effects on disease progression. The combined treatment resulted in a significantly greater improvement in both VAS pain and WOMAC scores when compared to core decompression alone. The use of bone marrow injection also demonstrated greater benefit in slowing or reversing disease progression (as assessed by MRI) compared to core decompression surgery alone.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
